EGFR and non-small cell lung carcinoma: Of the 50 cases of NSCLC that had EGFR mutations in primary tumors, exon 19 mutations (in-frame deletions only) were present in 28 cases (56%), and exon 21 (L858R point mutations only) mutations were detected in 22 cases (44%).